OVEX Fertility May Acquire Vaccine Maker

United Press International

OVEX Fertility Corp. said it is engaged in preliminary talks concerning the acquisition of Selcore Laboratories Inc., a developer of vaccines.

The discussions have proposed an acquisition using about 1.7 million shares of OVEX stock representing about 38% of the shares outstanding after the transaction.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World